Mersana Therapeutics
Price & Volume
Stats
See more52W Range | $5.21-$70.72 |
Market Cap | $137.6M |
Shares Short | 300,400 |
Financials
See moreRevenue (12 Mos) | $33.1M |
Revenue Growth (YoY) | -12.6% |
Gross Profit (12 Mos) | -$35.8M |
Diluted EPS | -$13.95 |
News
See moreYahoo Finance • yesterday
Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Yahoo Finance • yesterday
HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN
Yahoo Finance • 13 days ago
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more
About
CEO | Dr. Martin H. Huber M.D. |
CFO | Mr. Brian C. DeSchuytner |
Address | 840 Memorial Drive, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 102 |
